Research and development investment based on measurement technology
First written in FY2016. 25 of 38 entries say "Restated". Latest entry: 2026-09-10.
No other company in this theme has enough history to compare yet.
- 2026-09-10AdvancedOther Disclosures
「In this announcement, as described in the attached reference document ①, we reported research results from performance evaluations conducted for various aspects of photomask defect repair and confirmed the technology's practical applicability. Holon is developing photomask defect-repair equipment equipped with an SEM column incorporating aberration-correction functionality, applying the electron-optics technologies it has developed through CD-SEM work. This announcement presents some of the research results obtained in that development.」
Holon announced research results confirming the practical viability of photomask defect-repair equipment using its CD-SEM electron-optics technology, based on evaluations of repair-process repeatability, dimensional controllability, finished shape, repair accuracy and post-repair optical characteristics. This represented concrete progress in R&D. - FY2026AdvancedAnnual report
「R&D staff totaled 397, or approximately 16.0% of the group's total employees, and total R&D expenditure for the current consolidated fiscal year was ¥5,695 million,」
The company maintained an R&D organization of 397 staff and R&D expenditure of ¥5,695 million, and achieved concrete results including the development of the HSS-1000, a next-generation electron-beam photomask dimensional measurement system for EUV masks for nodes of 1.6 nm and beyond. - FY2026-H1RestatedAnnual report
「The group's total R&D expenditure for the current interim consolidated accounting period was ¥2,814 million. There were no material changes in the status of the group's R&D activities during the current interim consolidated accounting period.」
R&D expenditure of ¥2,814 million was recorded for the interim period, with no material changes in R&D activities. - FY2025AdvancedAnnual report
「R&D staff totaled 402, or approximately 16.5% of the group's total employees, and total R&D expenditure for the current consolidated fiscal year was ¥5,963 million,」
The R&D organization expanded to 402 staff, with R&D expenditure of ¥5,963 million. Disclosed development results include CD-SEMs, electron guns, temperature emulators for electric vehicles, and HILS boards for in-vehicle Ethernet. - FY2025-H1RestatedAnnual report
「The group's total R&D expenditure for the current interim consolidated accounting period was ¥2,860 million. There were no material changes in the status of the group's R&D activities during the current interim consolidated accounting period.」
R&D expenditure of ¥2,860 million was recorded, with activities continuing without any material changes. - FY2024AdvancedAnnual report
「R&D staff totaled 401, or approximately 16.2% of the group's total employees, and total R&D expenditure for the current consolidated fiscal year was ¥5,101 million,」
With 401 R&D staff and R&D expenditure of ¥5,101 million, the company developed battery simulation test equipment for electric vehicles, a mass spectrometer for measuring low-concentration H2 gas, a health management app, and an NFC-enabled cuffless blood pressure monitor. - FY2024-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,752 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,752 million was recorded, with activities continuing without any material changes. - FY2024-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,509 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,509 million was recorded, with no material changes in R&D activities. - FY2023-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,713 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,713 million was recorded, with no material changes in R&D activities. - FY2023-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,585 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,585 million was recorded, with no material changes in R&D activities. - FY2023-Q1RestatedAnnual report
「Total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥1,235 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure of ¥1,235 million was recorded, with no material changes in R&D activities. - FY2022AdvancedAnnual report
「This year, we launched a motor HILS (Hardware-in-the-Loop Simulation) product jointly developed with トヨタテクニカルディベロップメント株式会社 (TTDC). The product incorporates an FPGA (Field Programmable Gate Array) device of the industry's largest scale and enables advanced simulation, generating considerable interest.」
With 402 R&D staff and R&D expenditure of ¥4,874 million, the company achieved concrete results including the launch of a motor HILS product, delivery of a tire HILS test rig, and prototyping and evaluation of semiconductor-related units. - FY2022-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,693 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,693 million was recorded for the cumulative third quarter, with no material changes in R&D activities. - FY2022-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,470 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,470 million was recorded, with no material changes in R&D activities. - FY2022-Q1RestatedAnnual report
「Total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥1,230 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure of ¥1,230 million was recorded for the first quarter, with no material changes in R&D activities. - FY2021AdvancedAnnual report
「We jointly developed and launched SILS products with 株式会社ユビキタス AI, which has been engaged in the sale and support of in-vehicle equipment development and testing tool products.」
With 399 R&D staff and R&D expenditure of ¥5,065 million, the company launched SILS products jointly developed with ユビキタスAI and introduced new tire-testing equipment and measurement instruments. - FY2021-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,679 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,679 million was recorded, with no material changes in R&D activities. - FY2021-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,425 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,425 million was recorded, with no material changes in R&D activities. - FY2021-Q1RestatedAnnual report
「Total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥1,163 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure of ¥1,163 million was recorded, with activities continuing without any material changes. - FY2020AdvancedAnnual report
「We have also seen a trend toward increased inquiries, particularly relating to electrification, and are focusing on developing HILS (Hardware-in-the-Loop Simulation) systems for bench testing of batteries, inverters, and motors, as well as virtual simulation of these components.」
The company is advancing HILS development for the CASE and electrification fields and is also working on test automation and remote monitoring software. R&D expenditure is ¥5,000 million, with 390 R&D staff. - FY2020-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,724 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,724 million was recorded for the cumulative third quarter, with no material changes in R&D activities. - FY2020-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,515 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,515 million was recorded for the cumulative second quarter, with no material changes in R&D activities. - FY2020-Q1RestatedAnnual report
「The group's total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥1,228 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure of ¥1,228 million was recorded, with no material changes in R&D activities. - FY2019AdvancedAnnual report
「By combining our compact three-axis force sensor, the Force Matrix Sensor (FMS), developed using our advanced sensor technology, with control technology, we developed the Dynamic Contact Force Testing Rig (DCFR). This product is a next-generation test rig capable of measuring dynamic tire contact-pressure distributions and has received high marks in Japan and overseas as equipment that enables measurement of physical phenomena that could not previously be identified.」
The R&D activities progressed to the product commercialization stage, with the development of the DCFR, which combines FMS and control technology, receiving recognition in Japan and overseas. - FY2019-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,621 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,621 million was recorded for the cumulative third quarter, with no material changes in R&D activities. - FY2019-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,409 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,409 million was recorded, with no material changes in R&D activities. - FY2019-Q1RestatedAnnual report
「The group's total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥1,176 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure of ¥1,176 million was recorded for the first quarter, with no material changes in R&D activities. - FY2018AdvancedAnnual report
「We developed HELIOS, a highly scalable HILS platform for building an integrated HILS system that combines these functions in a single system. The platform is already in actual operation at an automotive company and has received high marks for its scalability.」
As an R&D initiative, the company developed the integrated HILS platform HELIOS and has progressed to the start of actual operations at an automotive company. - FY2018-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,541 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,541 million was recorded, with no material changes in R&D activities. - FY2018-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,424 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,424 million was recorded, with no material changes in R&D activities. - FY2018-Q1RestatedAnnual report
「The group's total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥1,184 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure of ¥1,184 million was recorded, with activities continuing without any material changes. - FY2017AdvancedAnnual report
「First, as part of strengthening the DSP system product lineup, we developed a new model of a compact, low-cost DSP system for embedded applications. Compared with conventional products, it achieves a 4- to 5-fold increase in processing speed at approximately the same cost.」
The R&D activities include concrete development results, such as achieving a 4- to 5-fold increase in processing speed over conventional products with the new DSP model. - FY2017-Q3RestatedAnnual report
「The group's total R&D expenditure for the cumulative third quarter of the current consolidated fiscal year was ¥3,331 million. There were no material changes in the status of the group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenditure of ¥3,331 million was recorded for the cumulative third quarter, with activities continuing without any material changes. - FY2017-Q2RestatedAnnual report
「The group's total R&D expenditure for the cumulative second quarter of the current consolidated fiscal year was ¥2,274 million. There were no material changes in the status of the group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenditure of ¥2,274 million was recorded, with activities continuing without any material changes. - FY2017-Q1RestatedAnnual report
「The group's total R&D expenditure for the cumulative first quarter of the current consolidated fiscal year was ¥1,151 million. There were no material changes in the status of the group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenditure of ¥1,151 million was recorded for the quarter, with activities continuing without any material changes. - FY2016First statedAnnual report
「Our group develops a wide range of measurement instruments within the business domain of “measurement.” The basic policy of our research and development activities is to develop instruments that meet customer requirements and pursue measurement technologies that support the future.」
With 408 R&D staff and R&D expenditure of ¥4,653 million, equivalent to 11.6% of sales, the group is advancing product development in DSPs, measurement instruments, semiconductor-related products, weighing instruments, and medical and healthcare equipment.